IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MESSA, PIERGIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.905
EU - Europa 13.313
AS - Asia 8.798
SA - Sud America 787
AF - Africa 160
OC - Oceania 148
Continente sconosciuto - Info sul continente non disponibili 16
Totale 37.127
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.374
GB - Regno Unito 4.311
CN - Cina 3.957
IT - Italia 3.047
SG - Singapore 1.982
SE - Svezia 1.532
DE - Germania 1.043
RU - Federazione Russa 844
IE - Irlanda 572
IN - India 528
BR - Brasile 515
FR - Francia 429
ID - Indonesia 402
JP - Giappone 401
CA - Canada 278
VN - Vietnam 230
TR - Turchia 218
NL - Olanda 209
HK - Hong Kong 199
MX - Messico 198
ES - Italia 191
KR - Corea 188
DK - Danimarca 178
UA - Ucraina 171
TW - Taiwan 156
FI - Finlandia 146
AU - Australia 128
BE - Belgio 115
CO - Colombia 97
CH - Svizzera 82
IR - Iran 81
TH - Thailandia 76
AT - Austria 71
GR - Grecia 64
EU - Europa 62
EG - Egitto 58
PK - Pakistan 57
PL - Polonia 55
AR - Argentina 51
PH - Filippine 50
RO - Romania 46
PE - Perù 42
MY - Malesia 40
PT - Portogallo 37
CL - Cile 33
IQ - Iraq 32
IL - Israele 29
RS - Serbia 29
SA - Arabia Saudita 28
NZ - Nuova Zelanda 20
MA - Marocco 19
NO - Norvegia 18
HU - Ungheria 17
LT - Lituania 16
VE - Venezuela 16
BD - Bangladesh 15
KE - Kenya 15
GT - Guatemala 14
CZ - Repubblica Ceca 13
EC - Ecuador 13
HN - Honduras 13
NG - Nigeria 13
ZA - Sudafrica 13
UZ - Uzbekistan 12
BG - Bulgaria 11
CY - Cipro 11
HR - Croazia 11
LK - Sri Lanka 11
NP - Nepal 11
OM - Oman 10
BO - Bolivia 9
KZ - Kazakistan 9
LB - Libano 9
SD - Sudan 9
SI - Slovenia 9
CR - Costa Rica 8
DZ - Algeria 8
TN - Tunisia 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
MK - Macedonia 7
JO - Giordania 6
KW - Kuwait 6
SY - Repubblica araba siriana 6
DO - Repubblica Dominicana 5
IS - Islanda 5
KH - Cambogia 5
MT - Malta 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
CU - Cuba 4
JM - Giamaica 4
LV - Lettonia 4
MD - Moldavia 4
MN - Mongolia 4
BH - Bahrain 3
BJ - Benin 3
EE - Estonia 3
Totale 37.132
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Chandler 1.269
Fairfield 1.204
Singapore 1.200
Houston 992
Milan 792
Ashburn 719
Princeton 695
Seattle 616
Beijing 598
Wilmington 570
Woodbridge 566
Council Bluffs 565
Dublin 553
Redwood City 503
Ann Arbor 477
Nanjing 440
Cambridge 400
Dearborn 290
Santa Clara 273
Hanover 267
Jakarta 267
Des Moines 266
Bengaluru 213
Boardman 212
Hangzhou 199
Rome 184
Shanghai 170
Guangzhou 167
Jinan 157
Shenzhen 149
Phoenix 143
Shenyang 139
Frankfurt am Main 133
Toronto 126
Nanchang 108
Tokyo 105
Hebei 102
Tianjin 100
Zhengzhou 100
San Diego 98
Changsha 97
Hong Kong 91
New York 90
Jacksonville 89
Taipei 88
Helsinki 82
Los Angeles 78
Dong Ket 74
Brussels 73
Mountain View 65
Silver Spring 64
Redmond 60
London 59
Jiaxing 57
Istanbul 56
Bogotá 54
Fuzhou 54
Central District 53
Berlin 52
Kunming 52
Nuremberg 52
Seoul 51
São Paulo 51
Bologna 49
Ottawa 47
Chicago 46
Bangkok 42
Chengdu 39
Madrid 38
Turin 38
Andover 37
Lanzhou 37
Munich 37
Bari 36
Wuhan 36
Duncan 35
Falls Church 34
Brescia 33
Vienna 33
Athens 32
Fremont 32
Mumbai 32
Washington 32
Florence 31
Haikou 31
Hanoi 31
Taiyuan 31
Somerville 30
Sakarya 29
Kent 28
Naples 28
Serra 28
Genoa 25
Ningbo 25
San Francisco 25
Sydney 25
Taizhou 25
Catania 24
Delhi 24
Totale 22.713
Salva come PNG Salva come JPEG
Nome #
Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 1.273
HCV, HBV, HIV ed emodialisi 843
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 644
Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier 582
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 578
Iperfosfatemia in dialisi: la scelta del chelante 557
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 544
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 482
Hepcidin levels in chronic hemodialysis patients : A critical evaluation 428
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 390
La doppia borsa di tabacco intorno alla cuffia profonda del catetere peritoneale: una tecnica per l’inizio immediato della CAPD [Double purse-string craft around the inner cuff: a new technique for an immediate start of CAPD] 342
I nuovi farmaci antivirali per la terapia di HCV post- trapianto renale 328
Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance 290
Farmaci ad azione antivirale diretta, epatite C e dialisi: un aggiornamento 284
Podocytes: Recent biomolecular developments 267
The long-term outcome of 93 patients with proliferative lupus nephritis 267
NeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic Sites 263
HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population 262
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey 258
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy] 229
Membranous Nephropathy (MN) Recurrence after Renal Transplantation 209
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study 208
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation 208
Natural history of hepatitis B and C in renal allograft recipients 204
How a skilful and motivated urinary sediment examination can save the kidneys 203
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 202
A new approach for anemia in kidney disease 200
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial 195
Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) 194
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 193
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 190
Pratica clinica per la diagnostica delle aritmie cardiache in pazienti in terapia renale sostitutiva: dati di una survey lombarda 188
Vitamin K in Chronic Kidney Disease 186
Pathophysiology of calcium and phosphate metabolism impairment in Chronic Kidney Disease 175
Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome 174
Long-term evaluation of coronary artery calcifications in kidney transplanted patients : a follow up of 5 years 174
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial 173
Physical performance and clinical outcomes in dialysis patients: A secondary analysis of the excite trial 167
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD 166
Fluorinated-PLGA Nanoparticles for Enhanced Drug Encapsulation and 19F-NMR Detection 163
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 161
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations 161
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update 160
FGF23-regulated production of Fetuin-A (AHSG) in osteocytes 158
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism 158
Kinetics of hepatitis B virus load during haemodialysis sessions and α-interferon: A prospective study 158
Discoidin domain receptor-1 and periostin: New players in chronic kidney disease 157
Nutritional vitamin D in renal transplant patients : speculations and reality 156
Trattamento dell’iperuricemia nel paziente nefropatico: è giunto il momento di agire? 156
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study 155
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: A novel model of glomerular damage 155
Luminex technology for anti-HLA antibody screening : evaluation of performance and of impact on laboratory routine 154
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients 154
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 149
ANCA-associated vasculitis with renal involvement 149
Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers 149
High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs 148
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients : results of the FARO-2 Cohort 145
Impact of the method of calculation on assessment of the PTH-calcium set point 145
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study 144
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation 144
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism 144
Ematuria che scompare in ospedale : una causa insolita 142
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 141
Vitamin and oxidative status in patients with systemic lupus erythematosus 140
Vitamin B12 status in patients with renal failure 139
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 138
FGF23 and Fetuin-A interaction in the liver and in the circulation 137
Behaviour of phosphate removal with different dialysis schedules 137
Use of the Frailty Index in Older Persons with Chronic Kidney Disease 137
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 137
Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis : Case Report and Review of the Literature 136
Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials 136
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis 136
Pathophysiology of Non Alcoholic Fatty Liver Disease 135
A dvanced glycation end products (ages) and soluble receptor for AGES (SRAGE): Association with risk of mortality in chronic kidney disease patients 135
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study 134
Native Hypovitaminosis D in CKD Patients : From Experimental Evidence to Clinical Practice 133
Ruolo della valutazione della morfologia delle emazia urinarie (VMEU) in pazienti con microematuria isolata di origine sconosciuta (MIOS) 132
The role of immunosuppression in malignancies among 351 pediatric renal transplant patients 132
Malignancies in 2753 kidney recipients transplanted during a 39-year experience 132
Hepatic disorders in chronic kidney disease 131
Persistent secondary hyperparathyroidism after renal transplantation 131
Functional renal involvement in normotensive patients with progressive systemic sclerosis: impaired sodium excretion during isotonic saline infusion 130
Carotid plaques in patients with long-term lupus nephritis 129
ADPKD : clinical issues before and after renal transplantation 127
FGF23 and vascular calcifications: Another piece of the puzzle? 126
Hepatorenal syndrome and novel advances in its management 126
Alport syndrome and pregnancy: a case series and literature review 125
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 125
Graphene quantum dots : from efficient preparation to safe renal excretion 125
Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of literature 124
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis 124
Uremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential : Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and Apoptosis 124
Iron citrate reduces high-phosphate induced vascular calcification by inhibiting osteo-chondrogenic shift of extracellular matrix in VSMCs 124
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome 124
Impact of HCV and Direct Acting Antivirals on Kidney Recipients: a retrospective study 123
Genetic factors and iron-related oxidative stress influence serum ferritin, associated with cardiovascular damage and mortality, in hemodialysis patients 122
Current indications to parathyroidectomy in CKD patients before and after renal transplantation 122
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 121
Totale 21.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.133 0 0 0 0 0 0 0 0 862 613 328 330
2020/20215.348 421 356 439 309 464 553 320 554 484 502 505 441
2021/20224.965 426 237 234 349 337 365 605 330 398 429 363 892
2022/20235.368 570 434 462 571 656 919 156 419 539 148 289 205
2023/20243.789 201 334 210 238 689 301 210 217 133 250 416 590
2024/20256.233 643 934 350 712 813 594 494 1.119 574 0 0 0
Totale 39.352